Candinas D et al. |
Efficacy of leflunomide in combination with current immunosuppressive agents in rat cardiac allotransplantation. |
1994 |
Transplant. Proc. |
pmid:7527959
|
Alessiani M et al. |
Adverse effects of FK 506 overdosage after liver transplantation. |
1993 |
Transplant. Proc. |
pmid:7679825
|
Nishikawa K et al. |
Experimental studies of vascularized joint allografts in rats. |
1994 |
Transplant. Proc. |
pmid:7513482
|
Abou-Jaoude MM et al. |
Cyclosporine microemulsion (Neoral) versus tacrolimus (FK506) as maintenance therapy in kidney transplant patients. |
2003 |
Transplant. Proc. |
pmid:14612103
|
Havrdova T et al. |
Effect of tacrolimus versus cyclosporine on glucose metabolism of pancreas and kidney recipients in the late (> 8 years) posttransplant period. |
2011 |
Transplant. Proc. |
pmid:22099774
|
Kobayashi M et al. |
FK 506 assay past and present--characteristics of FK 506 ELISA. |
1991 |
Transplant. Proc. |
pmid:1721258
|
Guitard J et al. |
Hepatitis C virus viral load after conversion from tacrolimus to cyclosporine in liver transplant patients: a pilot study. |
2007 |
Transplant. Proc. |
pmid:17954189
|
Bechstein WO et al. |
Tacrolimus (FK 506) therapy is associated with a significant reduction in immunosuppressive treatment failures following primary liver transplantation. |
1996 |
Transplant. Proc. |
pmid:8623211
|
Undre NA et al. |
Pharmacokinetics of FK 506 and mycophenolic acid after the administration of a FK 506-based regimen in combination with mycophenolate mofetil in kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636527
|
Park K et al. |
Efficacy of tacrolimus in primary kidney transplant patients: multicenter, open-label prospective study. |
2000 |
Transplant. Proc. |
pmid:11119901
|
Gruessner RW et al. |
Mycophenolate mofetil and tacrolimus for induction and maintenance therapy after pancreas transplantation. |
1998 |
Transplant. Proc. |
pmid:9532156
|
Rahamimov R et al. |
Rejection rate in living donor kidney transplantation with and without basiliximab in tacrolimus/mycophenolate mofetil-based protocol. |
2003 |
Transplant. Proc. |
pmid:12644082
|
Gavela MartÃnez E et al. |
Use of basiliximab induction in low-immunological risk renal transplant recipients receiving tacrolimus-based immunosuppression. |
2009 Jul-Aug |
Transplant. Proc. |
pmid:19715913
|
Hayashi S et al. |
Adenovirus-mediated gene transfer to the xenogeneic liver in liver xenotransplantation: the transduction of complement regulatory factor genes (DAF and HRF20). |
1997 |
Transplant. Proc. |
pmid:9193595
|
Sgrosso JL et al. |
Histopathological findings in heart transplant patients under tacrolimus-mycophenolate mofetil versus cyclosporine microemulsion-azathioprine. |
2002 |
Transplant. Proc. |
pmid:11959214
|
Ohara K et al. |
Toxicologic evaluation of FK 506. |
1990 |
Transplant. Proc. |
pmid:1689910
|
Nalesnik MA et al. |
The effect of FK 506 and CyA on the Lewis rat renal ischemia model. |
1990 |
Transplant. Proc. |
pmid:1689911
|
Charpentier B |
An induction versus no-induction protocol in anticalcineurin-based immunosuppression using very low-dose steroids. |
2001 |
Transplant. Proc. |
pmid:11406262
|
Weir MR |
Methods and outcomes of calcineurin inhibitor reduction or withdrawal in patients with chronic allograft nephropathy after the first year posttransplantation. |
2001 |
Transplant. Proc. |
pmid:11406264
|
Land W et al. |
Mycophenolate mofetil monotherapy: an optimal, safe, and efficacious immunosuppressive maintenance regimen in kidney transplant patients. |
2001 |
Transplant. Proc. |
pmid:11406265
|
Fukuzaki T et al. |
Induction of unresponsiveness to islet allograft by preoperative donor spleen cell injection and FK 506 treatment. |
1993 |
Transplant. Proc. |
pmid:7680173
|
Loréal O et al. |
FK 506 is less cytotoxic than cyclosporine to human and rat hepatocytes in vitro. |
1991 |
Transplant. Proc. |
pmid:1721289
|
Matsuzaki T et al. |
Liver transplantation for diethylnitrosamine-induced hepatocellular carcinoma in rats. |
1992 |
Transplant. Proc. |
pmid:1373547
|
McCauley J et al. |
Cyclosporine and FK 506 induced inhibition of renal epithelial cell proliferation. |
1991 |
Transplant. Proc. |
pmid:1721290
|
Ghobrial RM et al. |
Retransplantation for recurrent hepatitis C following tacrolimus or cyclosporine immunosuppression. |
1998 |
Transplant. Proc. |
pmid:9636597
|
Ciancio G et al. |
Human donor bone marrow cells can enhance hyporeactivity in renal transplantation using maintenance FK 506 and OKT3 induction therapy. |
1996 |
Transplant. Proc. |
pmid:8623473
|
Nakamura M et al. |
Clinical and radiological features of two cases of tacrolimus-related posterior leukoencephalopathy in living related liver transplantation. |
1998 |
Transplant. Proc. |
pmid:9636600
|
Imamura M et al. |
FK 506 inhibits severe graft-versus-host disease without mediating cytokine balance and/or cytotoxic molecules. |
2000 |
Transplant. Proc. |
pmid:11120238
|
D'Silva M et al. |
Immunosuppressive effect of brequinar on rat cardiac allograft survival in combination with leflunomide or FK 506. |
1996 |
Transplant. Proc. |
pmid:8623476
|
Forsythe J |
Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. The European Multicentre Tacrolimus/MMF Study Group. |
1999 |
Transplant. Proc. |
pmid:10576049
|
Bilodeau JF et al. |
Evaluation of tolerability and ability to increase immunosuppression in renal transplant patients converted from mycophenolate mofetil to enteric-coated mycophenolate sodium. |
2009 |
Transplant. Proc. |
pmid:19917367
|
Resch B et al. |
FK 506 and successful pregnancy in a patient after renal transplantation. |
1998 |
Transplant. Proc. |
pmid:9474990
|
Woo J et al. |
Flow cytometric analysis of lymphocyte populations and activation antigen expression in blood and lymphoid tissues of FK 506-treated rats. |
1990 |
Transplant. Proc. |
pmid:1697112
|
Murase N et al. |
Small bowel transplantation in sensitized recipients: comparison with heart, kidney, and liver grafts. |
1994 |
Transplant. Proc. |
pmid:7518139
|
Yu Y et al. |
Mutagenicity of the new immunosuppressive drugs, FK 506, and spergualin. |
1993 |
Transplant. Proc. |
pmid:7682364
|
Gaweco AS et al. |
Common and sequential overexpression patterns of T-helper cytokines during acute (cellular) rejection, and correlation of proinflammatory cytokine expression with chronic (ductopenic) rejection of human liver allografts: a study under cyclosporine, FK 506, and quadruple BT 563 immunosuppression. |
1995 |
Transplant. Proc. |
pmid:7533370
|
Takaori K et al. |
Effects of FK 506 on in vivo immunity in comparison to cyclosporine. |
1991 |
Transplant. Proc. |
pmid:1721322
|
Moscicka M et al. |
The effect of cyclosporine and tacrolimus on indigenous bacterial flora in human skin grafts. |
2003 |
Transplant. Proc. |
pmid:14529942
|
Kim HC et al. |
Primary immunosuppression with tacrolimus in renal transplantation: a single center experience. |
2003 |
Transplant. Proc. |
pmid:12591370
|
Tada H et al. |
Impact of CYP3A5 and MDR1(ABCB1) C3435T polymorphisms on the pharmacokinetics of tacrolimus in renal transplant recipients. |
2005 |
Transplant. Proc. |
pmid:15919447
|
Borrows R et al. |
Tacrolimus monitoring in renal transplantation: a comparison between high-performance liquid chromatography and immunoassay. |
2005 |
Transplant. Proc. |
pmid:15919448
|
Hodge EE et al. |
Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on cyclosporine or tacrolimus-randomized, prospective, multicenter study results. |
2002 |
Transplant. Proc. |
pmid:12176477
|
Funayama Y et al. |
Changes in cell adhesion molecules after small bowel transplantation in rats. |
1995 |
Transplant. Proc. |
pmid:7533426
|
Ahlmén J et al. |
Positive effects of tacrolimus in a case of CIDP. |
1998 |
Transplant. Proc. |
pmid:9865344
|
Paul AA et al. |
CMV retinitis and the use of FK 506. |
1991 |
Transplant. Proc. |
pmid:1721354
|
Cicero A and Lappin JA |
Pancreas transplantation: experience at University of Texas, Houston. |
2010 Jan-Feb |
Transplant. Proc. |
pmid:20172339
|
Barten MJ et al. |
Pharmacodynamics of the immunosuppressive effects of the combination of tacrolimus with mycophenolate mofetil. |
2002 |
Transplant. Proc. |
pmid:12270442
|
Forgacs B et al. |
Successful conversion to rapamycin for calcineurin inhibitor-related neurotoxicity following liver transplantation. |
2005 |
Transplant. Proc. |
pmid:15919502
|
Gaber LW et al. |
Renal histology with varying FK506 blood levels. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9122955
|
Cohen DS et al. |
Porcine small bowel transplantation with rapamycin-based induction immunosuppression and short-course cyclosporine or FK 506 therapy. |
1996 |
Transplant. Proc. |
pmid:8907923
|
Yoshimura N et al. |
Safety analysis following tacrolimus immunosuppression in renal transplant recipients in Japan: 3-year results in over 1000 patients. |
2002 |
Transplant. Proc. |
pmid:12176501
|
De Paolis P et al. |
"Immuknow" to measurement of cell-mediated immunity in renal transplant recipients undergoing short-term evaluation. |
2011 |
Transplant. Proc. |
pmid:21620039
|
Renner FC et al. |
Tacrolimus intoxication resolved by gastrointestinal bleeding: case report. |
2007 |
Transplant. Proc. |
pmid:17362773
|
Jain AB et al. |
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. |
1991 |
Transplant. Proc. |
pmid:1703354
|
Masaoka T |
Problems of bone marrow transplantation in Japan. |
1994 |
Transplant. Proc. |
pmid:7520634
|
Sho M et al. |
Simultaneous inoculation of donor lymphocyte subsets with transplantation in a rat cardiac allograft model. |
1998 |
Transplant. Proc. |
pmid:9838696
|
McCauley J et al. |
Renal function after conversion from cyclosporine to FK 506 in liver transplant patients. |
1991 |
Transplant. Proc. |
pmid:1721387
|
Kramer MR et al. |
Dose adjustment and cost of itraconazole prophylaxis in lung transplant recipients receiving cyclosporine and tacrolimus (FK 506). |
1997 |
Transplant. Proc. |
pmid:9290780
|
Tashiro H et al. |
Correlation of high-level microchimerism with graft acceptance in rat liver transplantation. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123287
|
Shapiro R et al. |
Reversibility of tacrolimus-induced posttransplant diabetes: an illustrative case and review of the literature. |
1997 |
Transplant. Proc. |
pmid:9290809
|
Wijnen RM et al. |
Thymus atrophy in the nonhuman primate by FK506: an immunohistochemical study. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123292
|
Ierardi E et al. |
Long-term tacrolimus: a promising therapeutic approach for Crohn's disease. |
2001 |
Transplant. Proc. |
pmid:11377467
|
Guckelberger O et al. |
Does the choice of primary immunosuppression influence the prevalence of cardiovascular risk factors after liver transplantation? |
1996 |
Transplant. Proc. |
pmid:8962230
|
Kumano K et al. |
Role of the transforming growth factor and monocyte chemoattractant protein in FK506-induced nephropathy in the rat. |
1997 Feb-Mar |
Transplant. Proc. |
pmid:9123293
|
Bilbao I et al. |
Comparison between tacrolimus and neoral cyclosporine administered by oral route in liver transplantation. |
2001 |
Transplant. Proc. |
pmid:11377472
|
Braun F et al. |
Clinical relevance of monitoring tacrolimus: comparison of microparticle enzyme immunoassay, enzyme-linked immunosorbent assay, and liquid chromatography mass spectrometry in renal transplant recipients converted from cyclosporine to tacrolimus. |
1996 |
Transplant. Proc. |
pmid:8962231
|
van Duijnhoven EM et al. |
Evidence that fasting does not significantly affect trough levels of tacrolimus in stable renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176552
|
Uchida J et al. |
Conversion of stable kidney transplant recipients from a twice-daily prograf to a once-daily tacrolimus formulation: a short-term study on its effects on glucose metabolism. |
2012 |
Transplant. Proc. |
pmid:22310596
|
Chen YB et al. |
Suitable calcineurin inhibitor concentrations for liver transplant recipients in the Chinese population. |
2011 |
Transplant. Proc. |
pmid:21693271
|
Kobayashi C et al. |
Suppression of corneal graft rejection in rabbits by a new immunosuppressive agent, FK-506. |
1989 |
Transplant. Proc. |
pmid:2468254
|
Reutzel-Selke A et al. |
Donor pretreatment of grafts from marginal donors improves long-term graft outcome. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267150
|
Masaoka T et al. |
Phase II study of FK 506 for allogeneic bone marrow transplantation. |
1991 |
Transplant. Proc. |
pmid:1721417
|
Tojimbara T et al. |
Cyclosporine and tacrolimus both suppress activation of Kupffer cells in vitro. |
1996 |
Transplant. Proc. |
pmid:8658704
|
Mabuchi M et al. |
Insulin-like growth factor-I enhances choleretic action of FK506 in rats. |
2003 |
Transplant. Proc. |
pmid:12826230
|
Lemahieu WP et al. |
Different evolution of trough and dose levels during the first year after transplantation for tacrolimus versus cyclosporine. |
2005 |
Transplant. Proc. |
pmid:15964336
|
Rayes N et al. |
Distribution of lymphocyte subtypes in liver transplant recipients with viral reinfection or de novo malignancy. |
1998 |
Transplant. Proc. |
pmid:9723303
|
McLaughlin GE et al. |
Use of phenobarbital in the management of acute tacrolimus toxicity: a case report. |
2000 |
Transplant. Proc. |
pmid:10812158
|
Lo A et al. |
Observations on the use of sirolimus and tacrolimus in high-risk renal transplant recipients. |
2003 |
Transplant. Proc. |
pmid:12742477
|
Polanco N et al. |
Everolimus-based immunosuppression therapy for BK virus nephropathy. |
|
Transplant. Proc. |
pmid:25645770
|
El-Sabrout R et al. |
Rejection-free protocol using sirolimus-tacrolimus combination for pediatric renal transplant recipients. |
2002 |
Transplant. Proc. |
pmid:12176636
|
Staak A et al. |
Immunoglobulin induction therapy in renal transplant recipients: Effects on immunoglobulin and regulatory antibody levels. |
2006 |
Transplant. Proc. |
pmid:17175311
|
Moray G et al. |
Comparison of histidine-tryptophan-ketoglutarate and University of Wisconsin in living-donor liver transplantation. |
2006 |
Transplant. Proc. |
pmid:17175334
|
Ochiai T et al. |
Prolongation of canine renal allograft survival by treatment with FK-506. |
1987 |
Transplant. Proc. |
pmid:2445075
|
Rayhill SC et al. |
A cyclosporine-based immunosuppressive regimen may be better than tacrolimus for long-term liver allograft survival in recipients transplanted for hepatitis C. |
2006 |
Transplant. Proc. |
pmid:17175350
|
Todo S et al. |
Canine kidney transplantation with FK-506 alone or in combination with cyclosporine and steroids. |
1987 |
Transplant. Proc. |
pmid:2445076
|
Nojima M et al. |
Immunosuppression Modification by Everolimus With Minimization of Calcineurin Inhibitors Recovers Kidney Graft Function Even in Patients With Very Late Conversion and Also With Poor Graft Function. |
|
Transplant. Proc. |
pmid:28104155
|
Collier DS et al. |
Kidney transplantation in the dog receiving FK-506. |
1987 |
Transplant. Proc. |
pmid:2445077
|
Jain A et al. |
Prospective randomized trial of tacrolimus and prednisone versus tacrolimus, prednisone, and mycophenolate mofetil: complete report on 350 primary adult liver transplantations. |
2001 Feb-Mar |
Transplant. Proc. |
pmid:11267319
|
Reichenspurner H et al. |
First experience with FK 506 for treatment of chronic pulmonary rejection. |
1995 |
Transplant. Proc. |
pmid:7540775
|
Percy C et al. |
Impact of Acute Infection Requiring Hospitalization on Tacrolimus Blood Levels in Kidney Transplant Recipients. |
2017 |
Transplant. Proc. |
pmid:29149962
|
Abu-Elmagd K et al. |
FK 506: a new therapeutic agent for severe recalcitrant psoriasis. |
1991 |
Transplant. Proc. |
pmid:1721449
|
Dé P et al. |
Early steroid-resistant rejection following orthotopic liver transplantation: new aspects of treatment with FK 506 instead of OKT3? |
1993 |
Transplant. Proc. |
pmid:7689279
|
Torregrosa JV et al. |
Combined liver-kidney transplantation: our experience. |
1999 |
Transplant. Proc. |
pmid:10500591
|
Ueda D et al. |
Influence of FK 506 on renal blood flow. |
1993 |
Transplant. Proc. |
pmid:7689280
|
Fischer S et al. |
Initial experience of combined immunosuppressive induction therapy with polyclonal antithymocyte antibody, FK 506 (tacrolimus), and prednisolone in clinical liver transplantation. |
2000 |
Transplant. Proc. |
pmid:11134815
|
Kelley M et al. |
Change in oral absorption of tacrolimus in a liver transplant recipient after reversal of jejunoileal bypass: case report. |
2005 |
Transplant. Proc. |
pmid:16213338
|
Hashi S et al. |
Assessment of four methodologies (microparticle enzyme immunoassay, chemiluminescent enzyme immunoassay, affinity column-mediated immunoassay, and flow injection assay-tandem mass spectrometry) for measuring tacrolimus blood concentration in Japanese liver transplant recipients. |
2014 |
Transplant. Proc. |
pmid:24767342
|
GarcÃa-Bello JA et al. |
Effect of Immunosuppressive Therapy on Cardiovascular Risk Factor Prevalence in Kidney-Transplanted Children: Comparative Study. |
2016 |
Transplant. Proc. |
pmid:27110020
|
Takahashi K et al. |
Tacrolimus therapy for ABO-incompatible kidney transplantation. |
1998 |
Transplant. Proc. |
pmid:9636495
|
Kanatani T et al. |
Experimental limb transplantation, part III: induction of tolerance in the rigorous strain combination of Brown Norway donor to Lewis recipient. |
2004 |
Transplant. Proc. |
pmid:15686745
|